SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Kazia Therapeutics maintained at Buy as BTIG raises target

BTIG maintained Kazia Therapeutics at Buy and raised its price target to $40.00 per share from $34.00, according to Benzinga via TradingView News.

KZIA

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories